News & Events
News & Events
November 29, 2023
C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOUTUCSON, Ariz. and LEBANON, N.H., November 29, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look to...
November 9, 2023
C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder TherapiesTUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics. A distinguished team of C-Path scientists and patient-advocates...
November 8, 2023
C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against TuberculosisC-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the AMR Accelerator. A new dawn in the fight against Tuberculosis UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces start of clinical trials 8 November 2023. Today, UNITE4TB, an international public-private partnership...
November 7, 2023
C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and EndocrinologyResearch confirms immune-based therapies improve outcomes in new-onset T1D TUCSON, Ariz., November 7, 2023 — Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announced the publishing of “C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes”...
October 30, 2023
eCOA Consortium Announces Publication of an Open Access ArticleC-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome Measures.” This article builds upon existing best practices for the electronic migration and implementation of patient-reported outcome measures to provide a comprehensive single point of...